GT Biopharma (GTBP) Return on Assets [ROA] (2009 - 2026)
GT Biopharma (GTBP) recorded Return on Assets [ROA] of -204.74% in Q2 2026, up 11.72 percentage points from -216.46% a year earlier but down 58.42 percentage points from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, GT Biopharma reported Return on Assets [ROA] of -201.43%, down 49.18 percentage points from FY2024.
- Annual Return on Assets [ROA] has a five-year change of +732.90 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -152.25% in FY2024 (-67.90 pp), -84.35% in FY2023 (+1.42 pp), -85.77% in FY2022 (+220.93 pp) and -306.70% in FY2021 (+627.62 pp).
- Quarterly Return on Assets [ROA] has ranged from -374.83% in Q1 2025 to 3.20% in Q3 2021 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has increased for three consecutive quarters, with an average year-over-year change of -40.23 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 228.52 percentage points in Q1 2026, against a drop of 790.42 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -146.32% (Q1 2026), -197.94% (Q4 2025) and -182.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 2.00% |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | -204.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -204.74% |
| Mar 31, 2026 | -146.32% |
| Dec 31, 2025 | -197.94% |
| Sep 30, 2025 | -182.18% |
| Jun 30, 2025 | -216.46% |
| Mar 31, 2025 | -374.83% |
| Dec 31, 2024 | -254.06% |
| Sep 30, 2024 | -165.31% |
| Jun 30, 2024 | -131.85% |
| Mar 31, 2024 | -101.95% |
| Dec 31, 2023 | -85.99% |
| Sep 30, 2023 | -89.56% |
| Jun 30, 2023 | -102.43% |
| Mar 31, 2023 | -104.44% |
| Dec 31, 2022 | -110.91% |
| Sep 30, 2022 | -149.53% |
| Jun 30, 2022 | -80.37% |
| Mar 31, 2022 | -44.66% |
| Dec 31, 2021 | -110.52% |
| Sep 30, 2021 | 3.20% |
API Access
GT Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();